patient no & affected eye |
age, sex |
IOP at NVG (IOP before NVG) ※1 |
OH or POAG ※2 |
NVE & NVD ※3 |
PRP density at the diagnosis of NVG |
Period between the first RP or PRP and NVG※4 |
Period between NVG and PRP ※5 |
IOP of 6 months after accomplishment of PRP, ※6 |
1 R |
63, M |
25 (15) |
- |
II→0, - |
24.2 |
20 m |
6 m |
15, + |
L |
|
35 (14) |
- |
I→0, |
19.8 |
28 m |
6 m |
15, + |
|
|
|
|
+→- |
|
|
|
|
2 R |
48, M |
26 (14) |
- |
I→0, - |
23.6 |
9 m |
4 m |
15, + |
L |
|
29 (14) |
- |
0→0, - |
37.3 |
7 m |
4 m |
13, + |
3 L |
65, F |
34 (12, 14) |
- |
I→0, - |
16.2 |
18 m |
6 m |
12, - |
4 R |
65, F |
28 (18, 18) |
- |
I→0, |
2.3 |
48 m |
3 m |
18, + |
|
|
|
|
+→- |
|
|
|
|
5 L |
70, M |
37 (12, 14) |
- |
I→0, - |
19.7 |
38 m |
6 m |
12, - |
6 L |
64, F |
36 (14, 13) |
- |
II→II, |
3.9 |
10 m |
4 m |
12, - |
|
|
|
|
+→- |
|
|
|
|
7 R |
49, F |
33 (16) |
- |
I→0, |
30.0 |
7 m |
8 m |
17, + |
|
|
|
|
+→- |
|
|
|
|
L |
|
36 (14) |
- |
I→0, - |
28.4 |
7 m |
8 m |
16, + |
8 R |
76, F |
24 (18, 18) |
- |
II→0, |
22.8 |
16 m |
15 m |
23, + |
|
|
|
|
+→- |
|
|
|
|
9 L |
61, M |
41 (17, 16) |
- |
I→0, |
20.0 |
64 m |
33 m |
38, +, GDI ※7 |
|
|
|
|
+→- |
|
|
|
|
GDI: glaucoma drainage implant, NVD: optic disc neovascularization, NVG: neovascular glaucoma, PRP: pan-retinal photocoagulation, RP: retinal
photocoagulation,
※ 1: Values in ( ) indicate IOP before the occurrence of neovascular glaucoma (NVG). Values in (,) indicate IOP of R & L eyes before the occurrence of NVG.
※ 2: Existence of ocular hypertension (OH) or primary open angle glaucoma (POAG) before occurrence of neovascular glaucoma.
※ 3: Neovascularization elsewhere (NVE) and optic disc neovascularization (NVD) before and after accomplishment of pan-retinal photocoagulation Number of NVE:
0=0, I=1-3, II=4>
※ 4: Period between the first RP or PRP and diagnosis of NVG
※ 5: Period between the diagnosis of neovascular glaucoma and achievement of PRP.
※ 6: +- indicates with or without topical anti-glaucoma medication.
※ 7: Glaucoma drainage surgery was performed for the left eye of Patient 9 within six months after the achievement of PRP |